Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Tissue Regenix Group (TRX) Share Price

Price 28.50p on 03-07-2025 at 18:40:07
Change 0.00p 0%
Buy 29.00p
Sell 28.00p
Buy / Sell TRX Shares
Last Trade: Buy 62.00 at 28.60p
Day's Volume: 8,583
Last Close: 28.50p
Open: 28.50p
ISIN: GB00BNTXR104
Day's Range 28.50p - 28.50p
52wk Range: 28.50p - 74.00p
Market Capitalisation: £20m
VWAP: 28.37052p
Shares in Issue: 71m

Tissue Regenix Group (TRX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 62 28.60p Ordinary
15:03:20 - 03-Jul-25
Buy* 832 28.60p Ordinary
14:25:59 - 03-Jul-25
Buy* 5 29.00p SI Trade
08:46:17 - 03-Jul-25
Buy* 100 29.00p SI Trade
08:46:17 - 03-Jul-25
Buy* 5 29.00p SI Trade
08:46:17 - 03-Jul-25
Buy* 3 29.00p SI Trade
08:46:17 - 03-Jul-25
Buy* 40 29.00p SI Trade
08:46:17 - 03-Jul-25
Buy* 4 29.00p SI Trade
08:46:17 - 03-Jul-25
Buy* 48 29.00p SI Trade
08:46:17 - 03-Jul-25
Sell* 4,000 28.00p Ordinary
08:46:08 - 03-Jul-25
See more Tissue Regenix Group trades

Tissue Regenix Group (TRX) Share Price History

Time period:
to
Date Open High Low Close Volume
3rd Jul 2025 (Thu) 28.50 28.50 28.50 28.50 8,583
2nd Jul 2025 (Wed) 29.50 29.50 28.50 28.50 103,102
1st Jul 2025 (Tue) 29.50 29.50 29.50 29.50 14,802
30th Jun 2025 (Mon) 29.50 29.50 29.50 29.50 85,969
27th Jun 2025 (Fri) 29.50 29.50 29.50 29.50 1,235,135
26th Jun 2025 (Thu) 31.00 31.00 29.50 29.50 56,002
25th Jun 2025 (Wed) 31.00 31.00 31.00 31.00 64,176
24th Jun 2025 (Tue) 30.50 31.00 30.50 30.50 135,907
23rd Jun 2025 (Mon) 30.50 30.50 30.50 30.50 28,285
20th Jun 2025 (Fri) 33.50 33.50 30.50 30.50 134,892
19th Jun 2025 (Thu) 33.50 33.50 33.50 33.50 10,259
18th Jun 2025 (Wed) 33.50 33.50 33.50 33.50 3,552
17th Jun 2025 (Tue) 33.50 33.50 33.50 33.50 62,076
16th Jun 2025 (Mon) 33.50 33.50 33.50 33.50 1,754
13th Jun 2025 (Fri) 34.00 34.00 33.00 33.50 24,283
12th Jun 2025 (Thu) 34.00 35.00 34.00 34.00 35,749
11th Jun 2025 (Wed) 32.00 34.00 32.00 34.00 93,888
10th Jun 2025 (Tue) 31.50 32.00 31.50 32.00 75,761
9th Jun 2025 (Mon) 31.50 33.00 31.50 31.50 143,464
6th Jun 2025 (Fri) 31.50 31.50 31.00 31.00 22,725
5th Jun 2025 (Thu) 32.00 32.00 31.50 31.50 45,219
4th Jun 2025 (Wed) 32.00 32.00 32.00 32.00 36,270
See more Tissue Regenix Group price history

Tissue Regenix Group (TRX) Regulatory News

Date Source Headline
27th Jun 2025 7:00 am RNS Posting of Annual Report & Notice of AGM
25th Jun 2025 7:00 am RNS Final results for the year ended 31 December 2024
9th Jun 2025 7:00 am RNS CE & UKCA certification for OrthoPure® XT
24th Apr 2025 9:38 am RNS Form 8.5 (EPT/NON-RI)- Tissue Regenix Group Plc
15th Apr 2025 9:23 am RNS Form 8.5 (EPT/NON-RI)
10th Apr 2025 9:09 am RNS Form 8.5 (EPT/NON-RI)
9th Apr 2025 10:45 am RNS Form 8.5 (EPT/NON-RI)
8th Apr 2025 7:00 am RNS Conclusion of Strategic Review & Offer Period
7th Apr 2025 8:46 am RNS Form 8.5 (EPT/NON-RI)
1st Apr 2025 9:12 am RNS Form 8.5 (EPT/NON-RI)
See more Tissue Regenix Group regulatory news

Tissue Regenix Group (TRX) Share News

Tissue Regenix narrows loss, eyes growth despite US market challenges

25th Jun 2025 13:23

(Alliance News) - Tissue Regenix Group PLC on Wednesday reported a narrower annual loss and record adjusted earnings, as it looks to future growth despite headwinds in parts of the US market. Read More

Tissue Regenix receives EU certification for OrthoPure XT technology

9th Jun 2025 11:22

(Alliance News) - Tissue Regenix Group PLC on Monday said it has received CE and UK Conformity Assessed certification for OrthoPure XT, its biological tendon replacement technology. Read More

IN BRIEF: Tissue Regenix granted European patent for dCELL

27th Mar 2025 20:17

Tissue Regenix Group PLC - Leeds, England-based regenerative medical devices company - Says European Patent Office grants European patent (EP4114476) for its decellularisation technology, dCELL. The patent relates to the method for producing decellularisation tissue scaffold which is a foundation for Tissue Regenix's platform and plays a pivotal role in the development of its product range. This patent adds to those the company already has granted in the US and UK for dCELL. Read More

IN BRIEF: Tissue Regenix eyes profit beat; plots German jv disposal

31st Jan 2025 21:30

Tissue Regenix Group PLC - Leeds, England-based regenerative medical devices company - Revenue increases 8% to USD28.4 million in the year ending December 31 from USD26.3 million a year prior. In addition, expects to report an adjusted earnings before interest, tax, depreciation and amortisation above expectations. Notes this will mark the second full year of profitability for Tissue Regenix and the fourth year of above-market growth. Read More

IN BRIEF: Tissue Regenix contacts firms as it considers possible sale

4th Nov 2024 18:21

Tissue Regenix Group PLC - Leeds, England-based regenerative medical devices company - In response to press reports, say that it is conducting a review of strategic options, which may include soliciting offers for Tissue Regenix. Accordingly, the firm has contacted a limited number of potential counterparties to assess whether they could put forward a proposal "that would deliver greater value to Tissue Regenix's shareholders than pursuing a standalone independent strategy". Says it has not received any indicative non-binding proposals to date, and says there can be no certainty any offer will be made. Read More

See more Tissue Regenix Group news
FTSE 100 Latest
Value8,823.20
Change48.51

Login to your account

Forgot Password?

Not Registered